PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $38 | -60.4% | 1,615 | -86.2% | 0.00% | -50.0% |
| Q4 2022 | $96 | -99.8% | 11,669 | -11.5% | 0.01% | +100.0% |
| Q3 2022 | $59,000 | +13.5% | 13,190 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $52,000 | -45.3% | 13,190 | -58.1% | 0.00% | -20.0% |
| Q1 2022 | $95,000 | +25.0% | 31,490 | -52.4% | 0.01% | +66.7% |
| Q4 2021 | $76,000 | -11.6% | 66,090 | +209.0% | 0.00% | -25.0% |
| Q3 2021 | $86,000 | +87.0% | 21,390 | +146.1% | 0.00% | +100.0% |
| Q2 2021 | $46,000 | +7.0% | 8,690 | +93.5% | 0.00% | 0.0% |
| Q1 2021 | $43,000 | +38.7% | 4,490 | -2.4% | 0.00% | +100.0% |
| Q4 2020 | $31,000 | +158.3% | 4,600 | -32.4% | 0.00% | – |
| Q3 2020 | $12,000 | -42.9% | 6,800 | -21.8% | 0.00% | -100.0% |
| Q2 2020 | $21,000 | +90.9% | 8,700 | +89.1% | 0.00% | +100.0% |
| Q1 2020 | $11,000 | -56.0% | 4,600 | -42.5% | 0.00% | -50.0% |
| Q4 2019 | $25,000 | -39.0% | 8,000 | -3.6% | 0.00% | -33.3% |
| Q3 2019 | $41,000 | +412.5% | 8,300 | +492.9% | 0.00% | – |
| Q2 2019 | $8,000 | – | 1,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 217,050 | $2,278,000 | 1.60% |
| Perceptive Advisors | 2,852,058 | $29,932,000 | 0.38% |
| 683 Capital Management, LLC | 630,000 | $6,612,000 | 0.35% |
| ADVISORY RESEARCH INC | 237,500 | $2,493,000 | 0.18% |
| GILDER GAGNON HOWE & CO LLC | 3,109,874 | $32,638,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 247,195 | $2,594,000 | 0.08% |
| Virtus ETF Advisers LLC | 16,158 | $170,000 | 0.07% |
| Walleye Capital LLC | 103,823 | $1,090,000 | 0.06% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 22,755 | $239,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 29,384 | $308,000 | 0.05% |